Skip to Content

252 b (Dipyridamole 25 mg)

Pill imprint 252 b has been identified as Dipyridamole 25 mg.

Dipyridamole is used in the treatment of radionuclide myocardial perfusion study; prosthetic heart valves - thrombosis prophylaxis and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Dipyridamole 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Dipyridamole 25 mg 252 b
Dipyridamole 25 mg 252 b Front
Dipyridamole 25 mg 252 b Back
Dipyridamole 25 mg 252 b
Dipyridamole
Imprint:
252 b
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardiac stressing agents
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0252
Inactive Ingredients:
silicon dioxide
hypromelloses
lactose anhydrous
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
propylene glycol
stearic acid
sodium starch glycolate type A potato
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide